Dr. Wang brings over 20 years of industry experience spanning biopharmaceuticals, medical devices, diagnostics, and management consulting. She has held senior strategy and innovation roles at Abbott, Stryker, Medtronic, and IQVIA, leading corporate strategy, portfolio investments, external partnerships, and commercialization initiatives. Her experience spans the full innovation lifecycle, from identifying emerging technologies and shaping R&D investments to developing commercialization strategies and launching innovative healthcare products. Dr. Wang earned her PhD in Neuroscience from Harvard University, where she conducted pioneering research on RNA interference and gene regulation in the laboratory of Nobel laureate Dr. Gary Ruvkun. She has published in leading scientific journals, including two papers in Nature. She also holds a BS in Biophysics and Physiology from Peking University in Beijing, China.